Ftse Mib
33.766,29
0,00%
DAX
19.916,56
0,00%
S&P 500
5.930,85
1,09%
NASDAQ
19.572,60
1,03%
Bitcoin
95.321,76
0,22%
Pepperstone
Advertisement
Registration Strip Icon for charts Registrati per grafici in tempo reale, strumenti di analisi e prezzi.
Registrati

Quotazioni in diretta

Non abbiamo trovato risultati per:
Assicurati di aver scritto correttamente o prova ad allargare la ricerca.

Più Attivi

Toplist

Sembra che tu non sia connesso.
Clicca il pulsante qui sotto per accedere e visualizzare la tua cronologia recente.

Registrati

Sei già registrato? Accedi

Pepperstone

Inizia Ora

Pepperstone
Home Investire Azioni U.S.A. NASDAQ Mustang Bio Inc (MBIO) Mustang Bio Inc (MBIO) Notizie

Mustang Bio Inc

MBIO
0,1796
0,0145 (8,78%)
21 Dic 2024 - Chiuso
Dati in Delay di 15 minuti
Borsa: NASDAQ
Tipo: Azione
Valuta: USD

Ultime notizie

Data Ora Fonte Titolo
06/12/202423:00EDGAR2Form DEF 14A - Other definitive proxy statements
02/12/202422:45EDGAR2Form 424B3 - Prospectus [Rule 424(b)(3)]
29/11/202406:15EDGAR2Form EFFECT - Notice of Effectiveness
22/11/202422:45EDGAR2Form S-3 - Registration statement under Securities Act of..
15/11/202422:50EDGAR2Form 8-K - Current report
12/11/202414:30GLOBEMustang Bio Receives Positive Listing Determination from..
08/11/202422:01EDGAR2Form 10-Q - Quarterly report [Sections 13 or 15(d)]
07/11/202414:30GLOBEMustang Bio Granted Orphan Drug Designation by U.S. FDA for..
06/11/202423:01EDGAR2Form 8-K - Current report
29/10/202421:05EDGAR2Form 3 - Initial statement of beneficial ownership of..
25/10/202422:45EDGAR2Form 8-K - Current report
24/10/202420:10GLOBEMustang Bio Announces Exercise of Warrants for $4 Million..
13/9/202422:30EDGAR2Form 8-K - Current report
16/8/202423:08EDGAR2Form 424B5 - Prospectus [Rule 424(b)(5)]
13/8/202422:01EDGAR2Form 10-Q - Quarterly report [Sections 13 or 15(d)]
19/7/202423:26EDGAR2Form S-1 - General form for registration of securities under..
10/7/202422:41EDGAR2Form DEF 14C - Other definitive information statements
21/6/202422:01GLOBEMustang Bio Announces Closing of $2.5 Million Registered..
20/6/202414:00GLOBEMustang Bio Announces $2.5 Million Registered Direct..
20/6/202414:00EDGAR2Form 424B5 - Prospectus [Rule 424(b)(5)]
17/6/202414:30GLOBEMustang Bio Announces Favorable Efficacy and Safety Data..
06/6/202423:00EDGAR2Form 8-K - Current report
05/6/202402:35EDGAR2Form 4 - Statement of changes in beneficial ownership of..
05/6/202402:33EDGAR2Form 4 - Statement of changes in beneficial ownership of..
31/5/202423:09EDGAR2Form S-3 - Registration statement under Securities Act of..
21/5/202422:15EDGAR2Form 8-K - Current report
13/5/202412:01EDGAR2Form 424B3 - Prospectus [Rule 424(b)(3)]
02/5/202422:01GLOBEMustang Bio Announces Closing of $4 Million Public Offering
30/4/202402:00GLOBEMustang Bio Announces Pricing of $4 Million Public Offering
28/3/202414:00GLOBEMustang Bio Announces Vision for CAR T-Cell Therapy Platform..
11/3/202421:30EDGAR2Form 8-K - Current report
11/3/202421:05GLOBEMustang Bio Reports Full-Year 2023 Financial Results and..
11/3/202421:02EDGAR2Form 10-K - Annual report [Section 13 and 15(d), not S-K..
07/3/202413:30GLOBEMustang Bio Announces Publication in Nature Medicine of Data..
14/2/202422:15EDGAR2Form 8-K - Current report
25/1/202422:07EDGAR2Form 8-K - Current report
11/1/202414:30GLOBEMustang Bio to Participate in the B. Riley Securities 4th..
04/1/202422:05EDGAR2Form 8-K - Current report
Apertura: 0,168 Min: 0,1652 Max: 0,1749
Chiusura: 0,1651

La tua Cronologia

NASDAQ
MBIO
Mustang Bio
Delayed Upgrade Clock

Il sito ADVFN Italia è stato realizzato ed è gestito da PRODESFIN su licenza di ADVFN PLC.

PER CONTATTI E PUBBLICITA' SUL SITO CLICCARE QUI

Accedendo ai servizi offerti da ADVFN, ne si accettano le condizioni generali Termini & Condizioni

ADVFN Network